Novo Nordisks GLP-1 agonist drug has been in huge demand so much so that it has been unable to meet it with current manufacturing capacity hamstrung by contract manufacturing problems but the company says it is getting those issues under control and expects the drug to help it post 24% to 30% sales growth this year
Li F, Wang J, Ma C, Zhao Y, Wang Y, Hasi A, Qi Z (2013) Glutamate receptor-like channel 3.3 is involved in mediating glutathione-triggered cytosolic calcium transients, transcriptional changes, and innate immunity responses in Arabidopsis
In many cases, biological activity has been evaluated mainly through in vitro metabolic assays and a limited set of cellular models, which complicates the establishment of firm conclusions regarding their mechanisms of action and actual selectivity
Nevertheless, since genotype 1 primers had been used to amplify the core region during Sanger sequencing and pangenotypic ones during NGS, it could be possible that the former ones had been able to amplify a minority population of 1b genomes that were below the NGS cut-off, i.e